AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ERLOTINIB HYDROCHLORIDE
19 registrations across 5 African markets— 18 active
Markets with ERLOTINIB HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ERLOCIP 150 TABLETS | 🇷🇼Rwanda | CIPLA LTD | active | Aug 2029 |
| ERLOCIP 100 TABLETS | 🇷🇼Rwanda | CIPLA LTD | active | Aug 2029 |
| ERLOCIP 150 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | CIPLA LTD | active | May 2029 |
| ERLOZ TABLETS | 🇬🇭Ghana | — | active | Aug 2028 |
| ERLOZ TABLETS | 🇬🇭Ghana | — | active | Aug 2028 |
| TYREC 150 | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Jan 2028 |
| TYREC 100 | 🇿🇦South Africa | Juno Pharma SA (Pty) Ltd | active | Jan 2028 |
| TYREC 25 | 🇿🇦South Africa | Juno Pharma SA (Pty) Ltd | active | Jan 2028 |
| ERLOTYK 150 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Dec 2027 |
| ERLOTINIB CIPLA 25 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2025 |
| ERLOTINIB CIPLA 100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ERLOCIP 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ERLOCIP 100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ERLOTINIB CIPLA 150 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ERLOCIP 25 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| ERLOTINIB
HYDROCHLORIDE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| ERLOTINIB
HYDROCHLORIDE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| ERLOTINIB
HYDROCHLORIDE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
| ERLOTINIB
HYDROCHLORIDE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | CIPLA LTD. | active | — |
ERLOTINIB HYDROCHLORIDE in Africa — Regulatory Overview
ERLOTINIB HYDROCHLORIDE is registered across 5 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Ghana, Rwanda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 19 registrations, 18 (95%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.